α-(3-Chlorphenyl)morpholinoacetonitril | 66548-90-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: α-(3-Chlorphenyl)morpholinoacetonitril
• 英文别名: α-(3-chlorophenyl)-4-morpholineacetonitrile；α-(m-chlorophenyl)-4-morpholineacetonitrile；(3-chloro-phenyl)-morpholin-4-yl-acetonitrile；2-(3-Chlorophenyl)-2-morpholinoacetonitrile；2-(3-chlorophenyl)-2-morpholin-4-ylacetonitrile
• CAS: 66548-90-1
• 化学式: C₁₂H₁₃ClN₂O
• mdl: MFCD10005169
• 分子量: 236.701
• InChiKey: FKXWOQFYOLHSJG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  36.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  α-(3-Chlorphenyl)morpholinoacetonitril 在 sodium hydride 、 copper(II) sulfate 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 1-(3-chlorophenyl)-4-(4-methylphenyl)-1,4-butanedione
  参考文献：
  名称：

  N-甲氧基-N-甲基-3-溴丙酰胺：一种新的三碳同系剂，用于合成不对称的1,4-二酮

  摘要：

  开发了一种基于α-氨基腈三碳同系物的合成路线，用于合成不对称的1,4-二酮。关键步骤是用N-甲氧基-N-甲基-3-溴丙酰胺对各种芳基和杂芳基α-氨基腈进行烷基化，然后将Grignard试剂添加到烷基化产物中，然后进行水解。

  DOI：

  10.1016/s0040-4020(01)00571-3
• 作为产物：
  描述：

  [2-(3-chlorophenyl)-2-morpholin-4-ylethenylidene]azanide 生成 α-(3-Chlorphenyl)morpholinoacetonitril
  参考文献：
  名称：

  BORDWELL, F. G.;BAUSCH, MARK J.;CHENG, JIN-PEI;CRIPE, THONAS H.;LYNCH, TS+, J. ORG. CHEM., 55,(1990) N, C. 58-63

  摘要：

  DOI：

文献信息

• Substituted thio-substituted benzyl-propionyl-L-prolines
  申请人：American Cyanamid Company

  公开号：US04226775A1

  公开（公告）日：1980-10-07

  This disclosure describes novel substituted .omega.-aroyl(propionyl or butyryl)-L-prolines and the esters and cationic salts thereof which are useful as hypotensive agents in mammals.

  这份披露描述了新型的取代的ω-芳酰基（丙酰基或丁酰基）-L-脯氨酸及其酯和阳离子盐，它们在哺乳动物中作为降血压剂是有用的。
• 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
  申请人：American Cyanamid Company

  公开号：US04112095A1

  公开（公告）日：1978-09-05

  This disclosure describes novel substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines useful as hypotensive agents.

  这份披露描述了作为降压药物有用的新型取代的6-苯基-1,2,4-三唑并[4,3-b]吡啶嗪。
• Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0010347A1

  公开（公告）日：1980-04-30

  The present invention provides novel substituted ω-aroyl(propionyl or butyryl) -L-prolines, pharmaceuticat compositions containing them useful for reducing blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, and processes for preparing the novel compounds. The novel compounds are those of the formulae: wherein n is zero or one; R is hydrogen or alkyl having up to 3 carbon atoms; R2 is hydrogen, phenyl or alkyl having up to 3 carbon atoms; R3 is mercapto, formylthio, benzoylthio, alt noylthio having from 2 to 4 carbon atoms or moieties of the formulae: and wherein R9 is phenyl or substituted phenyl; R4 is hydrogen, phenyl or alkyl having up to 4 carbon atoms; R5 is hydrogen or alkyl having up to 4 carbon atoms; and ARYL is selected from the group consisting of 1-naphthyl, 2-naphthyl, 4-chloro-1-naphthyl, 5, 6,7, 8-tetrahydro -1-naphthyl, 5, 6, 7, 8-tetrahydro -2-naphthyl, 4-methoxy-1 -naphthyl, 5-acenaphthyl, 4-biphenylyl, 5-indanyl, 4-indanyl and moieties of the formula: wherein R6 is selected from the group consisting of hydrogen, fluoro, chloro, bromo, trifluoromethyl, cyano, amino, phenoxy, halophenoxy, phenylthio, halophenylthio, p-cyclohexylphenoxy, alkyl having up to 4 carbon atoms, alkoxy having up to4 carbon atoms, alkylamino having up to 4 carbon atoms, alkanoylamino having from 2 to 4 carbon atoms and alkoxycarbonyl having from 2 to 4 carbon atoms, R- is selected from the group consisting of chloro, fluoro, bromo, alkyl having up to 4 carbon atoms and alkoxy having up to 4 carbon atoms, and m is zero, one or two; and the pharmacologically acceptable cationic salts thereof when R5 is hydrogen.

  本发明提供了新型取代的ω-芳酰基（丙酰基或丁酰基）-L-脯氨酸、含有它们的通过抑制血管紧张素Ⅰ向血管紧张素Ⅱ的转化来降低血压的药物组合物，以及制备这些新型化合物的工艺。新型化合物为以下式中的化合物： 其中 n 为 0 或 1；R 为氢或最多 3 个碳原子的烷基；R2 为氢、苯基或最多 3 个碳原子的烷基；R3 为巯基、甲硫基、苯甲酰硫基、具有 2 至 4 个碳原子的烷基硫基或式中的分子： 其中 R9 是苯基或取代苯基；R4 是氢、苯基或最多 4 个碳原子的烷基；R5 是氢或最多 4 个碳原子的烷基；ARYL 选自由 1-萘基、2-萘基、4-氯-1-萘基、5、6、7、8-四氢-1-萘基、5、6、7、8-四氢-2-萘基、4-甲氧基-1-萘基、5-苊基、4-联苯基、5-茚基、4-茚基和式如下的分子组成的组： 其中 R6 选自由氢、氟、氯、溴、三氟甲基、氰基、氨基、苯氧基、卤代苯氧基、苯硫基、卤代苯硫基、对环己基苯氧基、最多 4 个碳原子的烷基、最多 4 个碳原子的烷氧基、最多 4 个碳原子的烷基氨基组成的组、R-选自由氯、氟、溴、最多 4 个碳原子的烷基和最多 4 个碳原子的烷氧基组成的组，且 m 为 0、1 或 2；及其药理学上可接受的阳离子盐（当 R5 为氢时）。
• Steric inhibition of synergistic radical stabilizing effects
  作者：F. G. Bordwell、Mark J. Bausch、Jin Pei Cheng、Thomas H. Cripe、Tsuei Yun Lynch、Mark E. Mueller

  DOI：10.1021/jo00288a012

  日期：1990.1
• Umpolung Strategy for the Synthesis of 2-Deoxy-<i>C</i>-aryl Glycosides:  A Serendipitous, Efficient Route for <i>C</i>-Furanoside Analogues
  作者：S. Vijayasaradhi、Indrapal Singh Aidhen

  DOI：10.1021/ol025794w

  日期：2002.5.1

  [GRAPHICS]2-Deoxy-C-aryl glycosides are potential synthetic targets as they form a very vital moiety of several biologically active natural products. This paper describes a synthetic route using an umpolung strategy, which has not been explored till date. Our synthetic endeavor led to a versatile intermediate aryl ketone 10, which has paved the way for two important classes of C-glycosides, viz, C-alkyl furanosides 12 and methyl 2-deoxy-C-aryl pyranosides 14.

表征谱图